Pharmaceuticals, Biotechnology and Life Sciences
PRESS RELEASE AB SCIENCE RECEIVES HEALTH CANADA APPROVAL LETTER TO COMMENCE PHASE I/II TRIAL OF AB8939 IN THE TREATMENT OF…
BOSTON, Sept. 21, 2021 (GLOBE NEWSWIRE) — In a release issued on Wednesday, September 21 by Rhythm Pharmaceuticals, Inc. (Nasdaq:…
– IMCIVREE is indicated for treatment of obesity and control of hunger associated with genetically confirmed loss-of-function biallelic pro-opiomelanocortin (POMC),…
TORONTO and CHICAGO, Sept. 21, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) announced…
Current Chief Accounting Officer Mark Bodenrader named as interim CFO Search underway for permanent successor CAMBRIDGE, Mass., Sept. 21, 2021…
FDA inspection of facilities is ongoing; US commercial launch remains on track for 4Q CY2021, pending FDA approval Stage 1…
New Partnership with Youth Organization STEM Paths Innovation Network (SPIN) Seeds Next Generation of Local Biotech TalentSEATTLE, Sept. 21, 2021…
CAMBRIDGE, Mass. and NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology…
The patent provides coverage for compounds that target the main protease of the SARS-CoV-2 virusCARLSBAD, Calif., Sept. 21, 2021 (GLOBE…
REDWOOD CITY, Calif., Sept. 21, 2021 (GLOBE NEWSWIRE) — PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (“PROCEPT”), a commercial-stage surgical robotics company…